0

Nephrology Collection
 101-120 of 2268 Articles
Academia and the Profession |  1 April 2008
Exploring the Geometry of Treatment Networks
Georgia Salanti, PhD; Fotini K. Kavvoura, MD; John P.A. Ioannidis, MD
Ann Intern Med. 2008;148(7):544-553. doi:10.7326/0003-4819-148-7-200804010-00011
Articles |  1 April 2008
Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis
Bryan Kestenbaum, MD, MS; Kyle D. Rudser, PhD; Ian H. de Boer, MD, MS; et al.
Ann Intern Med. 2008;148(7):501-508. doi:10.7326/0003-4819-148-7-200804010-00006
Editorials |  4 March 2008
Trials That Matter: The Effect of a Fixed-Dose Combination of an Angiotensin-Converting Enzyme Inhibitor and a Diuretic on the Complications of Type 2 Diabetes
George L. Bakris, MD; Michael Berkwits, MD, MSCE, Deputy Editor
Ann Intern Med. 2008;148(5):400-401. doi:10.7326/0003-4819-148-5-200803040-00012
Reviews |  19 February 2008 FREE
Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
Aine M. Kelly, MD, MS; Ben Dwamena, MD; Paul Cronin, MD, MS; et al.
Ann Intern Med. 2008;148(4):284-294. doi:10.7326/0003-4819-148-4-200802190-00007
Articles |  15 January 2008
A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study
Nisha I. Parikh, MD, MPH; Michael J. Pencina, PhD; Thomas J. Wang, MD; et al.
Ann Intern Med. 2008;148(2):102-110. doi:10.7326/0003-4819-148-2-200801150-00005
Editorials |  1 January 2008 FREE
Inhibitors of the Renin–Angiotensin System: Proven Benefits, Unproven Safety
Patrick S. Parfrey, MD
Ann Intern Med. 2008;148(1):76-77. doi:10.7326/0003-4819-148-1-200801010-00191
Reviews |  1 January 2008 FREE
Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
Regina Kunz, MD, MSc(Epi); Chris Friedrich, MD; Marcel Wolbers, PhD; et al.
Ann Intern Med. 2008;148(1):30-48. doi:10.7326/0003-4819-148-1-200801010-00190
Reviews |  1 January 2008 FREE
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
David B. Matchar, MD; Douglas C. McCrory, MD, MHS; Lori A. Orlando, MD, MHS; et al.
Ann Intern Med. 2008;148(1):16-29. doi:10.7326/0003-4819-148-1-200801010-00189
Editorials |  18 December 2007
Vitamin D in Patients with Chronic Kidney Disease: Nothing New under the Sun
Marcello Tonelli, MD, SM
Ann Intern Med. 2007;147(12):880-881. doi:10.7326/0003-4819-147-12-200712180-00009
Reviews |  18 December 2007
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
Suetonia C. Palmer, MBChB; David O. McGregor, PhD; Petra Macaskill, PhD; et al.
Ann Intern Med. 2007;147(12):840-853. doi:10.7326/0003-4819-147-12-200712180-00004
Articles |  6 November 2007
Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis
Javier D. Finkielman, MD; Peter A. Merkel, MD, MPH; Darrell Schroeder, MS; et al.
Ann Intern Med. 2007;147(9):611-619. doi:10.7326/0003-4819-147-9-200711060-00005
Articles |  4 September 2007
Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients
Peter M. Okin, MD; Richard B. Devereux, MD; Katherine E. Harris, DrPH; et al.
Ann Intern Med. 2007;147(5):311-319. doi:10.7326/0003-4819-147-5-200709040-00006
Articles |  4 September 2007
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes
Keith A.A. Fox, MBChB; Jean-Pierre Bassand, MD; Shamir R. Mehta, MD; et al.
Ann Intern Med. 2007;147(5):304-310. doi:10.7326/0003-4819-147-5-200709040-00005
Articles |  21 August 2007 FREE
Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy
William A. Gahl, MD, PhD; Joan Z. Balog, RN, MSN; Robert Kleta, MD, PhD
Ann Intern Med. 2007;147(4):242-250. doi:10.7326/0003-4819-147-4-200708210-00006
Articles |  3 July 2007
Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
Vandana Menon, MD, PhD; Michael G. Shlipak, MD, MPH; Xuelei Wang, MS; et al.
Ann Intern Med. 2007;147(1):19-27. doi:10.7326/0003-4819-147-1-200707030-00004
Articles |  3 April 2007
Geography Matters: Relationships among Urban Residential Segregation, Dialysis Facilities, and Patient Outcomes
Rudolph A. Rodriguez, MD; Saunak Sen, PhD; Kala Mehta, DSc; et al.
Ann Intern Med. 2007;146(7):493-501. doi:10.7326/0003-4819-146-7-200704030-00005
Editorials |  20 March 2007
Trials That Matter: Rosiglitazone, Ramipril, and the Prevention of Type 2 Diabetes
David M. Nathan, MD; Michael Berkwits, MSCE, Deputy Editor
Ann Intern Med. 2007;146(6):461-463. doi:10.7326/0003-4819-146-6-200703200-00015
Articles |  6 February 2007
Octogenarians and Nonagenarians Starting Dialysis in the United States
Manjula Kurella, MD, MPH; Kenneth E. Covinsky, MD, MPH; Alan J. Collins, MD; et al.
Ann Intern Med. 2007;146(3):177-183. doi:10.7326/0003-4819-146-3-200702060-00006
Editorials |  16 January 2007 FREE
Enzyme Replacement in Fabry Disease: The Essence Is in the Kidney
Raphael Schiffmann, MD
Ann Intern Med. 2007;146(2):142-144. doi:10.7326/0003-4819-146-2-200701160-00147
Articles |  16 January 2007 FREE
Agalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial
Maryam Banikazemi, MD; Jan Bultas, MD, PhD; Stephen Waldek, MB, BCh; et al.
Ann Intern Med. 2007;146(2):77-86. doi:10.7326/0003-4819-146-2-200701160-00148
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)